|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Operating Costs and Expenses | |||||
| Cost of sales | |||||
| Operating and administrative expenses | |||||
| Impairment of goodwill | |||||
| Restructuring and related charges | |||||
| Amortization of intangible assets | |||||
| Total costs and expenses | |||||
| Operating income | |||||
| Interest expense | |||||
| Net foreign exchange transaction losses | |||||
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | |||||
| Other (expense) income, net | |||||
| Income (loss) before taxes | |||||
| (Benefit) provision for income taxes | |||||
| Net income (loss) | |||||
| Earnings (loss) per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...